Company intelligence / Profile preview

Mankind Specialties

Ownership: Private
Employees: ~22000
Development stage: Commercial

Overview

Mankind Pharma is India's 4th largest pharmaceutical company with a diverse portfolio across multiple therapeutic areas. The specialty division has expanded from two to nine therapeutic segments in four years

Therapeutic areas: Men's HealthPulmonologyOncologyEndocrinologyInfectious DiseasesDermatologyGastroenterologyCardiovascularNeurologyWomen's Health
Modalities: Small moleculesbiologicsrecombinant technology
Industry: Biotech

Drug pipeline

1 asset

insulin glargine

Commercial

Indications: Diabetes

Partnerships

AstraZeneca (Symbicort)Novartis (Crenzlo and Vonalong)Takeda (Vonolang and Vonoprazan)

Beyond the preview

Go deeper on Mankind Specialties.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mankind Specialties.

Explore the full profile